Global Metagenomic Sequencing Market By Offerings (Reagents and Consumables, Instruments, Services, Analysis & Data Interpretation Solutions); By Workflow (Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis); By Technology (Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, Metatranscriptomics, Whole-genome Sequencing & De Novo Assembly); By Application (Drug Discovery, Clinical Diagnostics, Soil Microbiome Applications, Industrial Applications, Ecological and Environmental Applications, Veterinary Applications, Other Applications); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In terms of revenue, global metagenomic sequencing market is expected to reach US$ 6.1 Bn by 2029, growing at an estimated CAGR of 20% over the forecast period (2022 – 2030). Understanding the root cause of any thing is extremely important as successful diagnosis is definitely a step towards correct treatment. This is exactly what metagenomics ensures when it comes to environmental health. Metagenomics basically is the detailed study of any genetic material that has been traced directly from the environment which is human gut, ocean water and soil. All this is then used to understand the diverse species along with right potential of microbes. The recent coronavirus pandemic that rattled the globe has directly contributed to the growth of the global metagenomic sequencing market. The infection which wasn’t known prior to year 2019 claimed lives of millions across the world. Post this several leading pharma and medical research companies have developed rapid testing kits along with vaccines for COVID-19 using advancements in sequencing.
Offerings Outlook
On the basis of offerings, the metagenomic sequencing market has been divided into reagents and consumables, instruments, services, analysis & data interpretation solutions. The reagents and consumables segment dominated in terms of market share in 2021. The reason behind this is advancements backed by commercialization of supreme quality reagents and kits. Meanwhile the demand for sequencing reagents have also skyrocketed.
Global Metagenomic Sequencing Market Revenue & Forecast, (US$ Million), 2022 – 2030
Technology Outlook
On the basis of technology, the metagenomic sequencing market has been divided into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, whole-genome sequencing & de novo assembly. The 16S rRNA sequencing segment makes most of the money for this market and this is basically because this gene happens to come up with a profile of diversity within a sample that is natural. Additionally this type of sequencing is not only accurate but also cost efficient.
Application Outlook
On the basis of application, the metagenomic sequencing market has been segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications and others. The drug discovery segment accounts for maximum amount of revenue generated by this market. Pharmaceutical companies are banking on data derived from studying the environmental elements.
Region Outlook
North America accounted for a dominant position in the metagenomic sequencing market in 2021. Presence of leading pharma and medical research companies that are willing to place higher bets on genomics research along with remarkable development in regards with NGS data analysis solutions has been rampantly driving the growth of this market in this region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global metagenomic sequencing market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global metagenomic sequencing market are listed below:
- Agilent Technologies, Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- ENTEROME
- Illumina, Inc.
- IntegraGen
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc
- Promega Corporation
- QIAGEN
- Swift Biosciences Inc.
- Thermo Fisher Scientific Inc.
- Other Market Participants
Global Metagenomic Sequencing Market
By Offerings
- Reagents and Consumables
- Instruments
- Services
- Analysis & Data Interpretation Solutions
By Workflow
- Sample Processing and Library Preparation
- Sequencing
- Data Processing and Analysis
By Technology
- Shotgun Metagenomic Sequencing
- 16S rRNA Sequencing
- Metatranscriptomics
- Whole-genome Sequencing & De Novo Assembly
By Application
- Drug Discovery
- Clinical Diagnostics
- Soil Microbiome Applications
- Industrial applications
- Ecological and Environmental Applications
- Veterinary Applications
- Others Applications
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Metagenomic Sequencing Market
6. Market Synopsis:
Metagenomic Sequencing Market
7. Metagenomic Sequencing Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Metagenomic Sequencing Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Metagenomic Sequencing Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Metagenomic Sequencing Market
8. Global Metagenomic Sequencing Market Analysis and Forecasts, 2022
– 2030
8.1. Overview
8.1.1. Global
Metagenomic Sequencing Market Revenue (US$ Mn)
8.2. Global
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Reagents
and Consumables
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 – 2030
8.2.2. Instruments
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.2.3. Services
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 – 2030
8.2.4. Analysis
and Data Interpretation Solutions
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2021
8.2.4.3. Market Forecast, 2022 – 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 – 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 – 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 – 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 – 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global Metagenomic Sequencing Market Analysis and Forecasts, 2022
– 2030
9.1. Overview
9.2. Global
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Workflow
9.2.1. Sample
Processing and Library Preparation
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. Sequencing
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. Data
Processing and Analysis
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Workflow
10. Global Metagenomic Sequencing Market Analysis and Forecasts, 2022
– 2030
10.1. Overview
10.2. Global
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Technology
10.2.1. Shotgun
Metagenomic Sequencing
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 – 2030
10.2.2. 16S
rRNA Sequencing
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.2.3. Metatranscriptomics
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 – 2030
10.2.4. Whole-genome
Sequencing and De Novo Assembly
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Technology
11. Global Metagenomic Sequencing Market Analysis and Forecasts, 2022
– 2030
11.1. Overview
11.2. Global
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Application
11.2.1. Drug
Discovery
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Clinical
Diagnostics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.2.3. Soil
Microbiome Applications
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 – 2030
11.2.4. Industrial
applications
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2021
11.2.4.3. Market Forecast, 2022 – 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022 – 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2021
11.2.4.5.3.2. Market
Forecast, 2022 – 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022 – 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022 – 2030
11.2.5. Ecological
and Environmental Applications
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2021
11.2.5.3. Market Forecast, 2022 – 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2021
11.2.5.5.1.2. Market
Forecast, 2022 – 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2021
11.2.5.5.2.2. Market
Forecast, 2022 – 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2021
11.2.5.5.3.2. Market
Forecast, 2022 – 2030
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2021
11.2.5.5.4.2. Market
Forecast, 2022 – 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2021
11.2.5.5.5.2. Market
Forecast, 2022 – 2030
11.2.6. Veterinary
Applications
11.2.6.1. Definition
11.2.6.2. Market Estimation and Penetration, 2015 - 2021
11.2.6.3. Market Forecast, 2022 – 2030
11.2.6.4. Compound Annual Growth Rate (CAGR)
11.2.6.5. Regional Bifurcation
11.2.6.5.1. North America
11.2.6.5.1.1. Market
Estimation, 2015 - 2021
11.2.6.5.1.2. Market
Forecast, 2022 – 2030
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 - 2021
11.2.6.5.2.2. Market
Forecast, 2022 – 2030
11.2.6.5.3. Asia Pacific
11.2.6.5.3.1. Market
Estimation, 2015 - 2021
11.2.6.5.3.2. Market
Forecast, 2022 – 2030
11.2.6.5.4. Middle East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 - 2021
11.2.6.5.4.2. Market
Forecast, 2022 – 2030
11.2.6.5.5. Latin America
11.2.6.5.5.1. Market
Estimation, 2015 - 2021
11.2.6.5.5.2. Market
Forecast, 2022 – 2030
11.2.7. Other
applications
11.2.7.1. Definition
11.2.7.2. Market Estimation and Penetration, 2015 - 2021
11.2.7.3. Market Forecast, 2022 – 2030
11.2.7.4. Compound Annual Growth Rate (CAGR)
11.2.7.5. Regional Bifurcation
11.2.7.5.1. North America
11.2.7.5.1.1. Market
Estimation, 2015 - 2021
11.2.7.5.1.2. Market
Forecast, 2022 – 2030
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 - 2021
11.2.7.5.2.2. Market
Forecast, 2022 – 2030
11.2.7.5.3. Asia Pacific
11.2.7.5.3.1. Market
Estimation, 2015 - 2021
11.2.7.5.3.2. Market
Forecast, 2022 – 2030
11.2.7.5.4. Middle East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 - 2021
11.2.7.5.4.2. Market
Forecast, 2022 – 2030
11.2.7.5.5. Latin America
11.2.7.5.5.1. Market
Estimation, 2015 - 2021
11.2.7.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By
Application
12. North America Metagenomic Sequencing Market Analysis and
Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North
America Metagenomic Sequencing Market Revenue (US$ Mn)
12.2. North
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.2.1. Reagents
and Consumables
12.2.2. Instruments
12.2.3. Services
12.2.4. Analysis
and Data Interpretation Solutions
12.3. North
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Workflow
12.3.1. Sample
Processing and Library Preparation
12.3.2. Sequencing
12.3.3. Data
Processing and Analysis
12.4. North
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Technology
12.4.1. Shotgun
Metagenomic Sequencing
12.4.2. 16S
rRNA Sequencing
12.4.3. Metatranscriptomics
12.4.4. Whole-genome
Sequencing and De Novo Assembly
12.5. North
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.1. Drug
Discovery
12.5.2. Clinical
Diagnostics
12.5.3. Soil
Microbiome Applications
12.5.4. Industrial
applications
12.5.5. Ecological
and Environmental Applications
12.5.6. Veterinary
Applications
12.5.7. Other
applications
12.6. North
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.6.1.1.1. Reagents and Consumables
12.6.1.1.2. Instruments
12.6.1.1.3. Services
12.6.1.1.4. Analysis and Data Interpretation Solutions
12.6.1.2. U.S Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
12.6.1.2.1. Sample Processing and Library Preparation
12.6.1.2.2. Sequencing
12.6.1.2.3. Data Processing and Analysis
12.6.1.3. U.S Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
12.6.1.3.1. Shotgun Metagenomic Sequencing
12.6.1.3.2. 16S rRNA Sequencing
12.6.1.3.3. Metatranscriptomics
12.6.1.3.4. Whole-genome Sequencing and De Novo Assembly
12.6.1.4. U.S Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.1.4.1. Drug Discovery
12.6.1.4.2. Clinical Diagnostics
12.6.1.4.3. Soil Microbiome Applications
12.6.1.4.4. Industrial applications
12.6.1.4.5. Ecological and Environmental Applications
12.6.1.4.6. Veterinary Applications
12.6.1.4.7. Other applications
12.6.2. Canada
12.6.2.1. Canada Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.6.2.1.1. Reagents and Consumables
12.6.2.1.2. Instruments
12.6.2.1.3. Services
12.6.2.1.4. Analysis and Data Interpretation Solutions
12.6.2.2. Canada Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
12.6.2.2.1. Sample Processing and Library Preparation
12.6.2.2.2. Sequencing
12.6.2.2.3. Data Processing and Analysis
12.6.2.3. Canada Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
12.6.2.3.1. Shotgun Metagenomic Sequencing
12.6.2.3.2. 16S rRNA Sequencing
12.6.2.3.3. Metatranscriptomics
12.6.2.3.4. Whole-genome Sequencing and De Novo Assembly
12.6.2.4. Canada Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.4.1. Drug Discovery
12.6.2.4.2. Clinical Diagnostics
12.6.2.4.3. Soil Microbiome Applications
12.6.2.4.4. Industrial applications
12.6.2.4.5. Ecological and Environmental Applications
12.6.2.4.6. Veterinary Applications
12.6.2.4.7. Other applications
12.6.3. Mexico
12.6.3.1. Mexico Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.6.3.1.1. Reagents and Consumables
12.6.3.1.2. Instruments
12.6.3.1.3. Services
12.6.3.1.4. Analysis and Data Interpretation Solutions
12.6.3.2. Mexico Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
12.6.3.2.1. Sample Processing and Library Preparation
12.6.3.2.2. Sequencing
12.6.3.2.3. Data Processing and Analysis
12.6.3.3. Mexico Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
12.6.3.3.1. Shotgun Metagenomic Sequencing
12.6.3.3.2. 16S rRNA Sequencing
12.6.3.3.3. Metatranscriptomics
12.6.3.3.4. Whole-genome Sequencing and De Novo Assembly
12.6.3.4. Mexico Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.4.1. Drug Discovery
12.6.3.4.2. Clinical Diagnostics
12.6.3.4.3. Soil Microbiome Applications
12.6.3.4.4. Industrial applications
12.6.3.4.5. Ecological and Environmental Applications
12.6.3.4.6. Veterinary Applications
12.6.3.4.7. Other applications
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Offerings
12.6.4.1.1. Reagents and Consumables
12.6.4.1.2. Instruments
12.6.4.1.3. Services
12.6.4.1.4. Analysis and Data Interpretation Solutions
12.6.4.2. Rest of North America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Workflow
12.6.4.2.1. Sample Processing and Library Preparation
12.6.4.2.2. Sequencing
12.6.4.2.3. Data Processing and Analysis
12.6.4.3. Rest of North America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Technology
12.6.4.3.1. Shotgun Metagenomic Sequencing
12.6.4.3.2. 16S rRNA Sequencing
12.6.4.3.3. Metatranscriptomics
12.6.4.3.4. Whole-genome Sequencing and De Novo Assembly
12.6.4.4. Rest of North America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Application
12.6.4.4.1. Drug Discovery
12.6.4.4.2. Clinical Diagnostics
12.6.4.4.3. Soil Microbiome Applications
12.6.4.4.4. Industrial applications
12.6.4.4.5. Ecological and Environmental Applications
12.6.4.4.6. Veterinary Applications
12.6.4.4.7. Other applications
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Offerings
12.7.3. By
Workflow
12.7.4. By
Technology
12.7.5. By
Application
13. Europe Metagenomic Sequencing Market Analysis and Forecasts, 2022
– 2030
13.1. Overview
13.1.1. Europe
Metagenomic Sequencing Market Revenue (US$ Mn)
13.2. Europe
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Offerings
13.2.1. Reagents
and Consumables
13.2.2. Instruments
13.2.3. Services
13.2.4. Analysis
and Data Interpretation Solutions
13.3. Europe
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Workflow
13.3.1. Sample
Processing and Library Preparation
13.3.2. Sequencing
13.3.3. Data
Processing and Analysis
13.4. Europe
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Technology
13.4.1. Shotgun
Metagenomic Sequencing
13.4.2. 16S
rRNA Sequencing
13.4.3. Metatranscriptomics
13.4.4. Whole-genome
Sequencing and De Novo Assembly
13.5. Europe
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1. Drug
Discovery
13.5.2. Clinical
Diagnostics
13.5.3. Soil
Microbiome Applications
13.5.4. Industrial
applications
13.5.5. Ecological
and Environmental Applications
13.5.6. Veterinary
Applications
13.5.7. Other
applications
13.6. Europe
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.1.1.1. Reagents and Consumables
13.6.1.1.2. Instruments
13.6.1.1.3. Services
13.6.1.1.4. Analysis and Data Interpretation Solutions
13.6.1.2. France Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.6.1.2.1. Sample Processing and Library Preparation
13.6.1.2.2. Sequencing
13.6.1.2.3. Data Processing and Analysis
13.6.1.3. France Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.1.3.1. Shotgun Metagenomic Sequencing
13.6.1.3.2. 16S rRNA Sequencing
13.6.1.3.3. Metatranscriptomics
13.6.1.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.1.4. France Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.4.1. Drug Discovery
13.6.1.4.2. Clinical Diagnostics
13.6.1.4.3. Soil Microbiome Applications
13.6.1.4.4. Industrial applications
13.6.1.4.5. Ecological and Environmental Applications
13.6.1.4.6. Veterinary Applications
13.6.1.4.7. Other applications
13.6.2. The UK
13.6.2.1. The UK Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.2.1.1. Reagents and Consumables
13.6.2.1.2. Instruments
13.6.2.1.3. Services
13.6.2.1.4. Analysis and Data Interpretation Solutions
13.6.2.2. The UK Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.6.2.2.1. Sample Processing and Library Preparation
13.6.2.2.2. Sequencing
13.6.2.2.3. Data Processing and Analysis
13.6.2.3. The UK Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.2.3.1. Shotgun Metagenomic Sequencing
13.6.2.3.2. 16S rRNA Sequencing
13.6.2.3.3. Metatranscriptomics
13.6.2.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.2.4. The UK Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.4.1. Drug Discovery
13.6.2.4.2. Clinical Diagnostics
13.6.2.4.3. Soil Microbiome Applications
13.6.2.4.4. Industrial applications
13.6.2.4.5. Ecological and Environmental Applications
13.6.2.4.6. Veterinary Applications
13.6.2.4.7. Other applications
13.6.3. Spain
13.6.3.1. Spain Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.3.1.1. Reagents and Consumables
13.6.3.1.2. Instruments
13.6.3.1.3. Services
13.6.3.1.4. Analysis and Data Interpretation Solutions
13.6.3.2. Spain Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.6.3.2.1. Sample Processing and Library Preparation
13.6.3.2.2. Sequencing
13.6.3.2.3. Data Processing and Analysis
13.6.3.3. Spain Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.3.3.1. Shotgun Metagenomic Sequencing
13.6.3.3.2. 16S rRNA Sequencing
13.6.3.3.3. Metatranscriptomics
13.6.3.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.3.4. Spain Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.4.1. Drug Discovery
13.6.3.4.2. Clinical Diagnostics
13.6.3.4.3. Soil Microbiome Applications
13.6.3.4.4. Industrial applications
13.6.3.4.5. Ecological and Environmental Applications
13.6.3.4.6. Veterinary Applications
13.6.3.4.7. Other applications
13.6.4. Germany
13.6.4.1. Germany Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.4.1.1. Reagents and Consumables
13.6.4.1.2. Instruments
13.6.4.1.3. Services
13.6.4.1.4. Analysis and Data Interpretation Solutions
13.6.4.2. Germany Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.6.4.2.1. Sample Processing and Library Preparation
13.6.4.2.2. Sequencing
13.6.4.2.3. Data Processing and Analysis
13.6.4.3. Germany Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.4.3.1. Shotgun Metagenomic Sequencing
13.6.4.3.2. 16S rRNA Sequencing
13.6.4.3.3. Metatranscriptomics
13.6.4.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.4.4. Germany Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.4.1. Drug Discovery
13.6.4.4.2. Clinical Diagnostics
13.6.4.4.3. Soil Microbiome Applications
13.6.4.4.4. Industrial applications
13.6.4.4.5. Ecological and Environmental Applications
13.6.4.4.6. Veterinary Applications
13.6.4.4.7. Other applications
13.6.5. Italy
13.6.5.1. Italy Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.6.5.1.1. Reagents and Consumables
13.6.5.1.2. Instruments
13.6.5.1.3. Services
13.6.5.1.4. Analysis and Data Interpretation Solutions
13.6.5.2. Italy Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
13.6.5.2.1. Sample Processing and Library Preparation
13.6.5.2.2. Sequencing
13.6.5.2.3. Data Processing and Analysis
13.6.5.3. Italy Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.5.3.1. Shotgun Metagenomic Sequencing
13.6.5.3.2. 16S rRNA Sequencing
13.6.5.3.3. Metatranscriptomics
13.6.5.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.5.4. Italy Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.5.4.1. Drug Discovery
13.6.5.4.2. Clinical Diagnostics
13.6.5.4.3. Soil Microbiome Applications
13.6.5.4.4. Industrial applications
13.6.5.4.5. Ecological and Environmental Applications
13.6.5.4.6. Veterinary Applications
13.6.5.4.7. Other applications
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Metagenomic Sequencing Market Revenue (US$
Mn) and Forecasts, By Offerings
13.6.6.1.1. Reagents and Consumables
13.6.6.1.2. Instruments
13.6.6.1.3. Services
13.6.6.1.4. Analysis and Data Interpretation Solutions
13.6.6.2. Nordic Countries Metagenomic Sequencing Market Revenue (US$
Mn) and Forecasts, By Workflow
13.6.6.2.1. Sample Processing and Library Preparation
13.6.6.2.2. Sequencing
13.6.6.2.3. Data Processing and Analysis
13.6.6.3. Nordic Countries Metagenomic Sequencing Market Revenue (US$
Mn) and Forecasts, By Technology
13.6.6.3.1. Shotgun Metagenomic Sequencing
13.6.6.3.2. 16S rRNA Sequencing
13.6.6.3.3. Metatranscriptomics
13.6.6.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.6.4. Nordic Countries Metagenomic Sequencing Market Revenue (US$
Mn) and Forecasts, By Application
13.6.6.4.1. Drug Discovery
13.6.6.4.2. Clinical Diagnostics
13.6.6.4.3. Soil Microbiome Applications
13.6.6.4.4. Industrial applications
13.6.6.4.5. Ecological and Environmental Applications
13.6.6.4.6. Veterinary Applications
13.6.6.4.7. Other applications
13.6.6.5. Nordic Countries Metagenomic Sequencing Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.6.7.1.1. Reagents and Consumables
13.6.7.1.2. Instruments
13.6.7.1.3. Services
13.6.7.1.4. Analysis and Data Interpretation Solutions
13.6.7.2. Benelux Union Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Workflow
13.6.7.2.1. Sample Processing and Library Preparation
13.6.7.2.2. Sequencing
13.6.7.2.3. Data Processing and Analysis
13.6.7.3. Benelux Union Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Technology
13.6.7.3.1. Shotgun Metagenomic Sequencing
13.6.7.3.2. 16S rRNA Sequencing
13.6.7.3.3. Metatranscriptomics
13.6.7.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.7.4. Benelux Union Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.7.4.1. Drug Discovery
13.6.7.4.2. Clinical Diagnostics
13.6.7.4.3. Soil Microbiome Applications
13.6.7.4.4. Industrial applications
13.6.7.4.5. Ecological and Environmental Applications
13.6.7.4.6. Veterinary Applications
13.6.7.4.7. Other applications
13.6.7.5. Benelux Union Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.6.8.1.1. Reagents and Consumables
13.6.8.1.2. Instruments
13.6.8.1.3. Services
13.6.8.1.4. Analysis and Data Interpretation Solutions
13.6.8.2. Rest of Europe Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Workflow
13.6.8.2.1. Sample Processing and Library Preparation
13.6.8.2.2. Sequencing
13.6.8.2.3. Data Processing and Analysis
13.6.8.3. Rest of Europe Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Technology
13.6.8.3.1. Shotgun Metagenomic Sequencing
13.6.8.3.2. 16S rRNA Sequencing
13.6.8.3.3. Metatranscriptomics
13.6.8.3.4. Whole-genome Sequencing and De Novo Assembly
13.6.8.4. Rest of Europe Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.8.4.1. Drug Discovery
13.6.8.4.2. Clinical Diagnostics
13.6.8.4.3. Soil Microbiome Applications
13.6.8.4.4. Industrial applications
13.6.8.4.5. Ecological and Environmental Applications
13.6.8.4.6. Veterinary Applications
13.6.8.4.7. Other applications
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By Offerings
13.7.3. By
Workflow
13.7.4. By
Technology
13.7.5. By
Application
14. Asia Pacific Metagenomic Sequencing Market Analysis and
Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn)
14.2. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.2.1. Reagents
and Consumables
14.2.2. Instruments
14.2.3. Services
14.2.4. Analysis
and Data Interpretation Solutions
14.3. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Workflow
14.3.1. Sample
Processing and Library Preparation
14.3.2. Sequencing
14.3.3. Data
Processing and Analysis
14.4. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Technology
14.4.1. Shotgun
Metagenomic Sequencing
14.4.2. 16S
rRNA Sequencing
14.4.3. Metatranscriptomics
14.4.4. Whole-genome
Sequencing and De Novo Assembly
14.5. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.1. Drug
Discovery
14.5.2. Clinical
Diagnostics
14.5.3. Soil
Microbiome Applications
14.5.4. Industrial
applications
14.5.5. Ecological
and Environmental Applications
14.5.6. Veterinary
Applications
14.5.7. Other
applications
14.6. Asia
Pacific Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.1.1.1. Reagents and Consumables
14.6.1.1.2. Instruments
14.6.1.1.3. Services
14.6.1.1.4. Analysis and Data Interpretation Solutions
14.6.1.2. China Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.1.2.1. Sample Processing and Library Preparation
14.6.1.2.2. Sequencing
14.6.1.2.3. Data Processing and Analysis
14.6.1.3. China Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.1.3.1. Shotgun Metagenomic Sequencing
14.6.1.3.2. 16S rRNA Sequencing
14.6.1.3.3. Metatranscriptomics
14.6.1.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.1.4. China Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.1.4.1. Drug Discovery
14.6.1.4.2. Clinical Diagnostics
14.6.1.4.3. Soil Microbiome Applications
14.6.1.4.4. Industrial applications
14.6.1.4.5. Ecological and Environmental Applications
14.6.1.4.6. Veterinary Applications
14.6.1.4.7. Other Applications
14.6.2. Japan
14.6.2.1. Japan Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.2.1.1. Reagents and Consumables
14.6.2.1.2. Instruments
14.6.2.1.3. Services
14.6.2.1.4. Analysis and Data Interpretation Solutions
14.6.2.2. Japan Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.2.2.1. Sample Processing and Library Preparation
14.6.2.2.2. Sequencing
14.6.2.2.3. Data Processing and Analysis
14.6.2.3. Japan Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.2.3.1. Shotgun Metagenomic Sequencing
14.6.2.3.2. 16S rRNA Sequencing
14.6.2.3.3. Metatranscriptomics
14.6.2.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.2.4. Japan Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.4.1. Drug Discovery
14.6.2.4.2. Clinical Diagnostics
14.6.2.4.3. Soil Microbiome Applications
14.6.2.4.4. Industrial applications
14.6.2.4.5. Ecological and Environmental Applications
14.6.2.4.6. Veterinary Applications
14.6.2.4.7. Other applications
14.6.3. India
14.6.3.1. India Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.3.1.1. Reagents and Consumables
14.6.3.1.2. Instruments
14.6.3.1.3. Services
14.6.3.1.4. Analysis and Data Interpretation Solutions
14.6.3.2. India Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.3.2.1. Sample Processing and Library Preparation
14.6.3.2.2. Sequencing
14.6.3.2.3. Data Processing and Analysis
14.6.3.3. India Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.3.3.1. Shotgun Metagenomic Sequencing
14.6.3.3.2. 16S rRNA Sequencing
14.6.3.3.3. Metatranscriptomics
14.6.3.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.3.4. India Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.4.1. Drug Discovery
14.6.3.4.2. Clinical Diagnostics
14.6.3.4.3. Soil Microbiome Applications
14.6.3.4.4. Industrial applications
14.6.3.4.5. Ecological and Environmental Applications
14.6.3.4.6. Veterinary Applications
14.6.3.4.7. Other applications
14.6.4. New
Zealand
14.6.4.1. New Zealand Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.4.1.1. Reagents and Consumables
14.6.4.1.2. Instruments
14.6.4.1.3. Services
14.6.4.1.4. Analysis and Data Interpretation Solutions
14.6.4.2. New Zealand Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.4.2.1. Sample Processing and Library Preparation
14.6.4.2.2. Sequencing
14.6.4.2.3. Data Processing and Analysis
14.6.4.3. New Zealand Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.4.3.1. Shotgun Metagenomic Sequencing
14.6.4.3.2. 16S rRNA Sequencing
14.6.4.3.3. Metatranscriptomics
14.6.4.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.4.4. New Zealand Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.4.4.1. Drug Discovery
14.6.4.4.2. Clinical Diagnostics
14.6.4.4.3. Soil Microbiome Applications
14.6.4.4.4. Industrial applications
14.6.4.4.5. Ecological and Environmental Applications
14.6.4.4.6. Veterinary Applications
14.6.4.4.7. Other applications
14.6.5. Australia
14.6.5.1. Australia Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.5.1.1. Reagents and Consumables
14.6.5.1.2. Instruments
14.6.5.1.3. Services
14.6.5.1.4. Analysis and Data Interpretation Solutions
14.6.5.2. Australia Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.5.2.1. Sample Processing and Library Preparation
14.6.5.2.2. Sequencing
14.6.5.2.3. Data Processing and Analysis
14.6.5.3. Australia Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.5.3.1. Shotgun Metagenomic Sequencing
14.6.5.3.2. 16S rRNA Sequencing
14.6.5.3.3. Metatranscriptomics
14.6.5.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.5.4. Australia Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.4.1. Drug Discovery
14.6.5.4.2. Clinical Diagnostics
14.6.5.4.3. Soil Microbiome Applications
14.6.5.4.4. Industrial applications
14.6.5.4.5. Ecological and Environmental Applications
14.6.5.4.6. Veterinary Applications
14.6.5.4.7. Other applications
14.6.6. South
Korea
14.6.6.1. South Korea Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.6.6.1.1. Reagents and Consumables
14.6.6.1.2. Instruments
14.6.6.1.3. Services
14.6.6.1.4. Analysis and Data Interpretation Solutions
14.6.6.2. South Korea Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
14.6.6.2.1. Sample Processing and Library Preparation
14.6.6.2.2. Sequencing
14.6.6.2.3. Data Processing and Analysis
14.6.6.3. South Korea Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.6.3.1. Shotgun Metagenomic Sequencing
14.6.6.3.2. 16S rRNA Sequencing
14.6.6.3.3. Metatranscriptomics
14.6.6.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.6.4. South Korea Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.4.1. Drug Discovery
14.6.6.4.2. Clinical Diagnostics
14.6.6.4.3. Soil Microbiome Applications
14.6.6.4.4. Industrial applications
14.6.6.4.5. Ecological and Environmental Applications
14.6.6.4.6. Veterinary Applications
14.6.6.4.7. Other applications
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.6.7.1.1. Reagents and Consumables
14.6.7.1.2. Instruments
14.6.7.1.3. Services
14.6.7.1.4. Analysis and Data Interpretation Solutions
14.6.7.2. Southeast Asia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Workflow
14.6.7.2.1. Sample Processing and Library Preparation
14.6.7.2.2. Sequencing
14.6.7.2.3. Data Processing and Analysis
14.6.7.3. Southeast Asia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Technology
14.6.7.3.1. Shotgun Metagenomic Sequencing
14.6.7.3.2. 16S rRNA Sequencing
14.6.7.3.3. Metatranscriptomics
14.6.7.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.7.4. Southeast Asia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.7.4.1. Drug Discovery
14.6.7.4.2. Clinical Diagnostics
14.6.7.4.3. Soil Microbiome Applications
14.6.7.4.4. Industrial applications
14.6.7.4.5. Ecological and Environmental Applications
14.6.7.4.6. Veterinary Applications
14.6.7.4.7. Other applications
14.6.7.5. Southeast Asia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.6.8.1.1. Reagents and Consumables
14.6.8.1.2. Instruments
14.6.8.1.3. Services
14.6.8.1.4. Analysis and Data Interpretation Solutions
14.6.8.2. Rest of Asia Pacific Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Workflow
14.6.8.2.1. Sample Processing and Library Preparation
14.6.8.2.2. Sequencing
14.6.8.2.3. Data Processing and Analysis
14.6.8.3. Rest of Asia Pacific Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Technology
14.6.8.3.1. Shotgun Metagenomic Sequencing
14.6.8.3.2. 16S rRNA Sequencing
14.6.8.3.3. Metatranscriptomics
14.6.8.3.4. Whole-genome Sequencing and De Novo Assembly
14.6.8.4. Rest of Asia Pacific Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.8.4.1. Drug Discovery
14.6.8.4.2. Clinical Diagnostics
14.6.8.4.3. Soil Microbiome Applications
14.6.8.4.4. Industrial applications
14.6.8.4.5. Ecological and Environmental Applications
14.6.8.4.6. Veterinary Applications
14.6.8.4.7. Other applications
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Offerings
14.7.3. By
Workflow
14.7.4. By
Technology
14.7.5. By
Application
15. Middle East and Africa Metagenomic Sequencing Market Analysis
and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn)
15.2. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
15.2.1. Reagents
and Consumables
15.2.2. Instruments
15.2.3. Services
15.2.4. Analysis
and Data Interpretation Solutions
15.3. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts,
By Workflow
15.3.1. Sample
Processing and Library Preparation
15.3.2. Sequencing
15.3.3. Data Processing
and Analysis
15.4. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts,
By Technology
15.4.1. Shotgun
Metagenomic Sequencing
15.4.2. 16S
rRNA Sequencing
15.4.3. Metatranscriptomics
15.4.4. Whole-genome
Sequencing and De Novo Assembly
15.5. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
15.5.1. Drug
Discovery
15.5.2. Clinical
Diagnostics
15.5.3. Soil
Microbiome Applications
15.5.4. Industrial
applications
15.5.5. Ecological
and Environmental Applications
15.5.6. Veterinary
Applications
15.5.7. Other
applications
15.6. Middle
East and Africa Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.6.1.1.1. Reagents and Consumables
15.6.1.1.2. Instruments
15.6.1.1.3. Services
15.6.1.1.4. Analysis and Data Interpretation Solutions
15.6.1.2. Saudi Arabia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Workflow
15.6.1.2.1. Sample Processing and Library Preparation
15.6.1.2.2. Sequencing
15.6.1.2.3. Data Processing and Analysis
15.6.1.3. Saudi Arabia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Technology
15.6.1.3.1. Shotgun Metagenomic Sequencing
15.6.1.3.2. 16S rRNA Sequencing
15.6.1.3.3. Metatranscriptomics
15.6.1.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.1.4. Saudi Arabia Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.1.4.1. Drug Discovery
15.6.1.4.2. Clinical Diagnostics
15.6.1.4.3. Soil Microbiome Applications
15.6.1.4.4. Industrial applications
15.6.1.4.5. Ecological and Environmental Applications
15.6.1.4.6. Veterinary Applications
15.6.1.4.7. Other applications
15.6.2. UAE
15.6.2.1. UAE Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.2.1.1. Reagents and Consumables
15.6.2.1.2. Instruments
15.6.2.1.3. Services
15.6.2.1.4. Analysis and Data Interpretation Solutions
15.6.2.2. UAE Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.6.2.2.1. Sample Processing and Library Preparation
15.6.2.2.2. Sequencing
15.6.2.2.3. Data Processing and Analysis
15.6.2.3. UAE Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
15.6.2.3.1. Shotgun Metagenomic Sequencing
15.6.2.3.2. 16S rRNA Sequencing
15.6.2.3.3. Metatranscriptomics
15.6.2.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.2.4. UAE Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.2.4.1. Drug Discovery
15.6.2.4.2. Clinical Diagnostics
15.6.2.4.3. Soil Microbiome Applications
15.6.2.4.4. Industrial applications
15.6.2.4.5. Ecological and Environmental Applications
15.6.2.4.6. Veterinary Applications
15.6.2.4.7. Other applications
15.6.3. Egypt
15.6.3.1. Egypt Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.3.1.1. Reagents and Consumables
15.6.3.1.2. Instruments
15.6.3.1.3. Services
15.6.3.1.4. Analysis and Data Interpretation Solutions
15.6.3.2. Egypt Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.6.3.2.1. Sample Processing and Library Preparation
15.6.3.2.2. Sequencing
15.6.3.2.3. Data Processing and Analysis
15.6.3.3. Egypt Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
15.6.3.3.1. Shotgun Metagenomic Sequencing
15.6.3.3.2. 16S rRNA Sequencing
15.6.3.3.3. Metatranscriptomics
15.6.3.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.3.4. Egypt Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.4.1. Drug Discovery
15.6.3.4.2. Clinical Diagnostics
15.6.3.4.3. Soil Microbiome Applications
15.6.3.4.4. Industrial applications
15.6.3.4.5. Ecological and Environmental Applications
15.6.3.4.6. Veterinary Applications
15.6.3.4.7. Other applications
15.6.4. Kuwait
15.6.4.1. Kuwait Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.6.4.1.1. Reagents and Consumables
15.6.4.1.2. Instruments
15.6.4.1.3. Services
15.6.4.1.4. Analysis and Data Interpretation Solutions
15.6.4.2. Kuwait Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
15.6.4.2.1. Sample Processing and Library Preparation
15.6.4.2.2. Sequencing
15.6.4.2.3. Data Processing and Analysis
15.6.4.3. Kuwait Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
15.6.4.3.1. Shotgun Metagenomic Sequencing
15.6.4.3.2. 16S rRNA Sequencing
15.6.4.3.3. Metatranscriptomics
15.6.4.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.4.4. Kuwait Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.4.1. Drug Discovery
15.6.4.4.2. Clinical Diagnostics
15.6.4.4.3. Soil Microbiome Applications
15.6.4.4.4. Industrial applications
15.6.4.4.5. Ecological and Environmental Applications
15.6.4.4.6. Veterinary Applications
15.6.4.4.7. Other applications
15.6.5. South
Africa
15.6.5.1. South Africa Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.6.5.1.1. Reagents and Consumables
15.6.5.1.2. Instruments
15.6.5.1.3. Services
15.6.5.1.4. Analysis and Data Interpretation Solutions
15.6.5.2. South Africa Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Workflow
15.6.5.2.1. Sample Processing and Library Preparation
15.6.5.2.2. Sequencing
15.6.5.2.3. Data Processing and Analysis
15.6.5.3. South Africa Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Technology
15.6.5.3.1. Shotgun Metagenomic Sequencing
15.6.5.3.2. 16S rRNA Sequencing
15.6.5.3.3. Metatranscriptomics
15.6.5.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.5.4. South Africa Metagenomic Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.5.4.1. Drug Discovery
15.6.5.4.2. Clinical Diagnostics
15.6.5.4.3. Soil Microbiome Applications
15.6.5.4.4. Industrial applications
15.6.5.4.5. Ecological and Environmental Applications
15.6.5.4.6. Veterinary Applications
15.6.5.4.7. Other applications
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Metagenomic Sequencing Market
Revenue (US$ Mn) and Forecasts, By Offerings
15.6.6.1.1. Reagents and Consumables
15.6.6.1.2. Instruments
15.6.6.1.3. Services
15.6.6.1.4. Analysis and Data Interpretation Solutions
15.6.6.2. Rest of Middle East & Africa Metagenomic Sequencing Market
Revenue (US$ Mn) and Forecasts, By Workflow
15.6.6.2.1. Sample Processing and Library Preparation
15.6.6.2.2. Sequencing
15.6.6.2.3. Data Processing and Analysis
15.6.6.3. Rest of Middle East & Africa Metagenomic Sequencing Market
Revenue (US$ Mn) and Forecasts, By Technology
15.6.6.3.1. Shotgun Metagenomic Sequencing
15.6.6.3.2. 16S rRNA Sequencing
15.6.6.3.3. Metatranscriptomics
15.6.6.3.4. Whole-genome Sequencing and De Novo Assembly
15.6.6.4. Rest of Middle East & Africa Metagenomic Sequencing Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.6.4.1. Drug Discovery
15.6.6.4.2. Clinical Diagnostics
15.6.6.4.3. Soil Microbiome Applications
15.6.6.4.4. Industrial applications
15.6.6.4.5. Ecological and Environmental Applications
15.6.6.4.6. Veterinary Applications
15.6.6.4.7. Other applications
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Offerings
15.7.3. By
Workflow
15.7.4. By
Technology
15.7.5. By
Application
16. Latin America Metagenomic Sequencing Market Analysis and
Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin
America Metagenomic Sequencing Market Revenue (US$ Mn)
16.2. Latin
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Offerings
16.2.1. Reagents
and Consumables
16.2.2. Instruments
16.2.3. Services
16.2.4. Analysis
and Data Interpretation Solutions
16.3. Latin
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Workflow
16.3.1. Sample
Processing and Library Preparation
16.3.2. Sequencing
16.3.3. Data
Processing and Analysis
16.4. Latin
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Technology
16.4.1. Shotgun
Metagenomic Sequencing
16.4.2. 16S
rRNA Sequencing
16.4.3. Metatranscriptomics
16.4.4. Whole-genome
Sequencing and De Novo Assembly
16.5. Latin
America Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By
Application
16.5.1. Drug
Discovery
16.5.2. Clinical
Diagnostics
16.5.3. Soil
Microbiome Applications
16.5.4. Industrial
applications
16.5.5. Ecological
and Environmental Applications
16.5.6. Veterinary
Applications
16.5.7. Other
applications
16.6. Latin America
Metagenomic Sequencing Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.6.1.1.1. Reagents and Consumables
16.6.1.1.2. Instruments
16.6.1.1.3. Services
16.6.1.1.4. Analysis and Data Interpretation Solutions
16.6.1.2. Brazil Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.6.1.2.1. Sample Processing and Library Preparation
16.6.1.2.2. Sequencing
16.6.1.2.3. Data Processing and Analysis
16.6.1.3. Brazil Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
16.6.1.3.1. Shotgun Metagenomic Sequencing
16.6.1.3.2. 16S rRNA Sequencing
16.6.1.3.3. Metatranscriptomics
16.6.1.3.4. Whole-genome Sequencing and De Novo Assembly
16.6.1.4. Brazil Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.4.1. Drug Discovery
16.6.1.4.2. Clinical Diagnostics
16.6.1.4.3. Soil Microbiome Applications
16.6.1.4.4. Industrial applications
16.6.1.4.5. Ecological and Environmental Applications
16.6.1.4.6. Veterinary Applications
16.6.1.4.7. Other applications
16.6.2. Argentina
16.6.2.1. Argentina Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.6.2.1.1. Reagents and Consumables
16.6.2.1.2. Instruments
16.6.2.1.3. Services
16.6.2.1.4. Analysis and Data Interpretation Solutions
16.6.2.2. Argentina Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Workflow
16.6.2.2.1. Sample Processing and Library Preparation
16.6.2.2.2. Sequencing
16.6.2.2.3. Data Processing and Analysis
16.6.2.3. Argentina Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Technology
16.6.2.3.1. Shotgun Metagenomic Sequencing
16.6.2.3.2. 16S rRNA Sequencing
16.6.2.3.3. Metatranscriptomics
16.6.2.3.4. Whole-genome Sequencing and De Novo Assembly
16.6.2.4. Argentina Metagenomic Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.4.1. Drug Discovery
16.6.2.4.2. Clinical Diagnostics
16.6.2.4.3. Soil Microbiome Applications
16.6.2.4.4. Industrial applications
16.6.2.4.5. Ecological and Environmental Applications
16.6.2.4.6. Veterinary Applications
16.6.2.4.7. Other applications
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Offerings
16.6.3.1.1. Reagents and Consumables
16.6.3.1.2. Instruments
16.6.3.1.3. Services
16.6.3.1.4. Analysis and Data Interpretation Solutions
16.6.3.2. Rest of Latin America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Workflow
16.6.3.2.1. Sample Processing and Library Preparation
16.6.3.2.2. Sequencing
16.6.3.2.3. Data Processing and Analysis
16.6.3.3. Rest of Latin America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Technology
16.6.3.3.1. Shotgun Metagenomic Sequencing
16.6.3.3.2. 16S rRNA Sequencing
16.6.3.3.3. Metatranscriptomics
16.6.3.3.4. Whole-genome Sequencing and De Novo Assembly
16.6.3.4. Rest of Latin America Metagenomic Sequencing Market Revenue
(US$ Mn) and Forecasts, By Application
16.6.3.4.1. Drug Discovery
16.6.3.4.2. Clinical Diagnostics
16.6.3.4.3. Soil Microbiome Applications
16.6.3.4.4. Industrial applications
16.6.3.4.5. Ecological and Environmental Applications
16.6.3.4.6. Veterinary Applications
16.6.3.4.7. Other applications
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Offerings
16.7.3. By
Workflow
16.7.4. By
Technology
16.7.5. By
Application
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2021
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Agilent
Technologies, Inc.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. BGI
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Bio-Rad
Laboratories, Inc.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. ENTEROME
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Illumina,
Inc.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. IntegraGen
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Oxford
Nanopore Technologies
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Pacific
Biosciences of California, Inc.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Promega
Corporation
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. QIAGEN
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Swift
Biosciences Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Thermo
Fisher Scientific Inc.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business Strategies
18.13. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
